The Therapeutic Sciences PhD Program is an exciting new program developed this month to be an
expansion and integration of our longstanding PhD programs in Molecular Pharmacology & Physiology
(MPP) and Biotechnology (Biotech). Although the Therapeutic Sciences PhD still covers pharmacology,
physiology and biotechnology, it also includes other fields that are part of the broader, expanding
discipline of therapeutics. For example, the program includes studies of drug targets in the immune
system that are important in treating infectious diseases, characterization of brain mechanisms of
addiction with an eye toward therapy, studies of molecular interactions in disease processes,
understanding and preventing cancer growth and metastasis, and applications of cell- and tissue-based
therapies, to name a few of the research foci. Thus, TSGP offers advanced training appropriate for
academic and research careers in the fields of biology and medical sciences with a focus on determining
disease mechanisms and drug actions, and developing novel therapies. The PhD program is funded in part
by an NIH training grant (T32) through the National Institute of General Medical Sciences (NIGMS)
Program in Pharmacological Sciences.

MPP, the main parent program of the TSGP PhD, has a very accomplished history and reputation for being
an intimate, very diverse and inclusive program with outstanding student outcomes. The Therapeutic
Sciences PhD program will retain these features and will preserve the atmosphere established in the MPP
program. To get a feel for the collaborative atmosphere in MPP, which will continue in TSGP, as well as
some of the research areas that also will carry over to TSGP, please watch this MPP video recorded in
2019, before the pandemic:

Here is a link to our program website:

And here is an email address for the program: